LIFE09200604007 Tabish - Homi Bhabha National Institute

Bibliography
166. Ying, X. J.; Dong, P.; Shen, B.; Wang, J.; Wang, S.; Wang, G., Possible association of NAT2
polymorphism with laryngeal cancer risk: an evidence-based meta-analysis. J Cancer Res Clin
Oncol 137, (11), 1661-7.
167. Gonzalez, M. V.; Alvarez, V.; Pello, M. F.; Menendez, M. J.; Suarez, C.; Coto, E., Genetic
polymorphism of N-acetyltransferase-2, glutathione S-transferase-M1, and cytochromes P450IIE1
and P450IID6 in the susceptibility to head and neck cancer. J Clin Pathol 1998, 51, (4), 294-8.
168. Hiyama, T.; Yoshihara, M.; Tanaka, S.; Chayama, K., Genetic polymorphisms and head and neck
cancer risk (Review). Int J Oncol 2008, 32, (5), 945-73.
169. Li, X.; Hu, Z.; Qu, X.; Zhu, J.; Li, L.; Ring, B. Z.; Su, L., Putative EPHX1 enzyme activity is
related with risk of lung and upper aerodigestive tract cancers: a comprehensive meta-analysis.
PLoS One 2011, 6, (3), e14749.
170. Hu, Y.; Benya, R. V.; Carroll, R. E.; Diamond, A. M., Allelic loss of the gene for the GPX1
selenium-containing protein is a common event in cancer. J Nutr 2005, 135, (12 Suppl), 3021S-
3024S.
171. Ratnasinghe, D.; Tangrea, J. A.; Andersen, M. R.; Barrett, M. J.; Virtamo, J.; Taylor, P. R.;
Albanes, D., Glutathione peroxidase codon 198 polymorphism variant increases lung cancer risk.
Cancer Res 2000, 60, (22), 6381-3.
172. Jefferies, S.; Kote-Jarai, Z.; Goldgar, D.; Houlston, R.; Frazer-Williams, M. J.; A'Hern, R.; Eeles,
R.; Henk, J.; Gore, M.; Rhys-Evans, P.; Archer, D.; Bishop, K.; Solomon, E.; Hodgson, S.;
McGurk, M.; Hibbert, J.; O'Connell, M.; Partridge, M.; Chevretton, E.; Calman, F.; Saunders, M.;
Shotton, K.; Brown, A.; Whittaker, S.; Foulkes, W., Association between polymorphisms of the
GPX1 gene and second primary tumours after index squamous cell cancer of the head and neck.
Oral Oncol 2005, 41, (5), 455-61.
173. Sherr, C. J., D-type cyclins. Trends Biochem Sci 1995, 20, (5), 187-90.
174. Nelsen, C. J.; Kuriyama, R.; Hirsch, B.; Negron, V. C.; Lingle, W. L.; Goggin, M. M.; Stanley,
M. W.; Albrecht, J. H., Short term cyclin D1 overexpression induces centrosome amplification,
mitotic spindle abnormalities, and aneuploidy. J Biol Chem 2005, 280, (1), 768-76.
175. Wang, T. C.; Cardiff, R. D.; Zukerberg, L.; Lees, E.; Arnold, A.; Schmidt, E. V., Mammary
hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 1994, 369, (6482), 669-
71.
176. Holley, S. L.; Matthias, C.; Jahnke, V.; Fryer, A. A.; Strange, R. C.; Hoban, P. R., Association of
cyclin D1 polymorphism with increased susceptibility to oral squamous cell carcinoma. Oral
Oncol 2005, 41, (2), 156-60.
177. Matthias, C.; Branigan, K.; Jahnke, V.; Leder, K.; Haas, J.; Heighway, J.; Jones, P. W.; Strange,
R. C.; Fryer, A. A.; Hoban, P. R., Polymorphism within the cyclin D1 gene is associated with
prognosis in patients with squamous cell carcinoma of the head and neck. Clin Cancer Res 1998,
4, (10), 2411-8.
178. Pabalan, N.; Bapat, B.; Sung, L.; Jarjanazi, H.; Francisco-Pabalan, O.; Ozcelik, H., Cyclin D1
Pro241Pro (CCND1-G870A) polymorphism is associated with increased cancer risk in human
populations: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2008, 17, (10), 2773-81.
179. Lei, D.; Sturgis, E. M.; Wang, L. E.; Liu, Z.; Zafereo, M. E.; Wei, Q.; Li, G., FAS and FASLG
genetic variants and risk for second primary malignancy in patients with squamous cell carcinoma
of the head and neck. Cancer Epidemiol Biomarkers Prev 2010, 19, (6), 1484-91.
180. Zhang, Z.; Wang, L. E.; Sturgis, E. M.; El-Naggar, A. K.; Hong, W. K.; Amos, C. I.; Spitz, M. R.;
Wei, Q., Polymorphisms of FAS and FAS ligand genes involved in the death pathway and risk
and progression of squamous cell carcinoma of the head and neck. Clin Cancer Res 2006, 12,
(18), 5596- 602.
181. Brant, O.; Hoffmann, M.; Kanappilly, A.; Gorogh, T.; Gottschlich, S., P53 codon 72
polymorphism in squamous cell carcinoma of the head and neck region. Anticancer Res 2007, 27,
(5A), 3301-5.
182. Shen, H.; Zheng, Y.; Sturgis, E. M.; Spitz, M. R.; Wei, Q., P53 codon 72 polymorphism and risk
of squamous cell carcinoma of the head and neck: a case-control study. Cancer Lett 2002, 183,
(2), 123-30.
158